| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocytes | 7 | 2014 | 225 | 1.070 |
Why?
|
| Liver Regeneration | 5 | 2013 | 38 | 1.020 |
Why?
|
| Hepatectomy | 5 | 2014 | 109 | 0.930 |
Why?
|
| Receptors, Purinergic P2Y2 | 3 | 2023 | 17 | 0.760 |
Why?
|
| Bacterial Infections | 1 | 2023 | 305 | 0.710 |
Why?
|
| Bacteremia | 1 | 2023 | 405 | 0.650 |
Why?
|
| Sepsis | 1 | 2023 | 477 | 0.640 |
Why?
|
| Adenosine Triphosphate | 5 | 2015 | 287 | 0.550 |
Why?
|
| Receptors, Purinergic P2X3 | 1 | 2015 | 3 | 0.520 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2014 | 5 | 0.480 |
Why?
|
| Liver | 7 | 2023 | 1734 | 0.370 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 220 | 0.360 |
Why?
|
| Nanoparticles | 2 | 2012 | 231 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 10 | 2023 | 4353 | 0.320 |
Why?
|
| Polynucleotides | 1 | 2008 | 9 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 206 | 0.310 |
Why?
|
| Cell Cycle | 4 | 2015 | 614 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 1872 | 0.300 |
Why?
|
| Ileum | 5 | 2021 | 131 | 0.290 |
Why?
|
| Adipose Tissue | 1 | 2010 | 464 | 0.290 |
Why?
|
| Mice, Knockout | 8 | 2023 | 3718 | 0.280 |
Why?
|
| Animals | 34 | 2023 | 33759 | 0.280 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 936 | 0.270 |
Why?
|
| Acetaldehyde | 3 | 1994 | 8 | 0.260 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 1309 | 0.260 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2001 | 10 | 0.240 |
Why?
|
| Lung | 4 | 2014 | 1476 | 0.240 |
Why?
|
| Signal Transduction | 8 | 2018 | 4489 | 0.240 |
Why?
|
| Carrier Proteins | 7 | 2002 | 1019 | 0.230 |
Why?
|
| Cells, Cultured | 6 | 2018 | 3042 | 0.230 |
Why?
|
| Mitogens | 1 | 2004 | 30 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 315 | 0.230 |
Why?
|
| Lipopolysaccharides | 3 | 2023 | 290 | 0.230 |
Why?
|
| Receptors, Purinergic | 1 | 2023 | 16 | 0.220 |
Why?
|
| Retinoid X Receptor alpha | 3 | 2009 | 17 | 0.220 |
Why?
|
| Nucleotides | 1 | 2023 | 92 | 0.210 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2014 | 38 | 0.210 |
Why?
|
| Mice | 14 | 2023 | 17503 | 0.210 |
Why?
|
| Gene Deletion | 2 | 2023 | 793 | 0.210 |
Why?
|
| Bile Acids and Salts | 5 | 2010 | 233 | 0.190 |
Why?
|
| Neurites | 1 | 2001 | 44 | 0.190 |
Why?
|
| Arginine | 1 | 2023 | 303 | 0.190 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 1999 | 54 | 0.190 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2021 | 39 | 0.180 |
Why?
|
| Amino Acids | 1 | 2023 | 658 | 0.180 |
Why?
|
| Intestinal Neoplasms | 1 | 2021 | 39 | 0.180 |
Why?
|
| Rats | 14 | 2009 | 3653 | 0.180 |
Why?
|
| Enterocytes | 1 | 2021 | 71 | 0.180 |
Why?
|
| Kidney | 6 | 2012 | 1337 | 0.170 |
Why?
|
| Myocardium | 2 | 2018 | 984 | 0.170 |
Why?
|
| Liposomes | 2 | 2012 | 169 | 0.170 |
Why?
|
| Cell Proliferation | 3 | 2015 | 2307 | 0.160 |
Why?
|
| Cytokines | 2 | 2023 | 1285 | 0.160 |
Why?
|
| Cholic Acids | 1 | 2018 | 16 | 0.160 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1907 | 0.160 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 98 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 280 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 2 | 2011 | 106 | 0.150 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2006 | 91 | 0.140 |
Why?
|
| Ankyrins | 1 | 1998 | 99 | 0.140 |
Why?
|
| Cardiotonic Agents | 1 | 2018 | 135 | 0.140 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 260 | 0.140 |
Why?
|
| Cell Division | 2 | 2011 | 780 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2015 | 1100 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 1996 | 210 | 0.130 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 12 | 0.130 |
Why?
|
| Cholic Acid | 2 | 2014 | 17 | 0.130 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 4 | 2002 | 28 | 0.120 |
Why?
|
| Symporters | 4 | 2002 | 66 | 0.120 |
Why?
|
| Cyclins | 1 | 2014 | 101 | 0.120 |
Why?
|
| Blood Proteins | 1 | 1994 | 116 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2014 | 76 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 1994 | 95 | 0.110 |
Why?
|
| Interleukin-1 | 2 | 2006 | 143 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1687 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 861 | 0.110 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2014 | 75 | 0.110 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 134 | 0.110 |
Why?
|
| Cholestasis | 2 | 2014 | 147 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2004 | 256 | 0.110 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2014 | 89 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1292 | 0.100 |
Why?
|
| Brain | 2 | 2001 | 2964 | 0.100 |
Why?
|
| Male | 15 | 2021 | 60117 | 0.100 |
Why?
|
| Homeostasis | 2 | 2015 | 682 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 224 | 0.100 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 162 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2012 | 98 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2015 | 365 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 368 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 137 | 0.090 |
Why?
|
| Glucose | 1 | 2015 | 872 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 381 | 0.090 |
Why?
|
| Bile Duct Diseases | 1 | 2010 | 17 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2009 | 14 | 0.080 |
Why?
|
| Transfection | 6 | 2006 | 1068 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 340 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1118 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2009 | 1213 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2001 | 572 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2010 | 176 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 478 | 0.080 |
Why?
|
| Purinergic P2 Receptor Antagonists | 2 | 2009 | 5 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 159 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 488 | 0.080 |
Why?
|
| Gene Expression | 3 | 2010 | 1566 | 0.080 |
Why?
|
| Mineral Oil | 1 | 2008 | 4 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2009 | 18 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 151 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3274 | 0.080 |
Why?
|
| Viscosity | 1 | 2008 | 35 | 0.080 |
Why?
|
| Emulsions | 1 | 2008 | 65 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2008 | 37 | 0.080 |
Why?
|
| Particle Size | 1 | 2008 | 116 | 0.080 |
Why?
|
| Cell Line | 6 | 2012 | 2771 | 0.080 |
Why?
|
| Transcriptome | 1 | 2014 | 905 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 351 | 0.070 |
Why?
|
| Rabbits | 3 | 2012 | 708 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2008 | 87 | 0.070 |
Why?
|
| Hepatitis, Animal | 1 | 2006 | 1 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2008 | 161 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2015 | 4710 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2006 | 79 | 0.070 |
Why?
|
| Base Sequence | 5 | 2006 | 3091 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1529 | 0.060 |
Why?
|
| Dogs | 4 | 1999 | 765 | 0.060 |
Why?
|
| Heart Failure | 1 | 2018 | 2127 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2002 | 100 | 0.060 |
Why?
|
| Cattle | 2 | 1999 | 558 | 0.060 |
Why?
|
| Heart | 1 | 2010 | 723 | 0.060 |
Why?
|
| Radioligand Assay | 2 | 2001 | 25 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2009 | 1608 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2004 | 89 | 0.060 |
Why?
|
| Molecular Weight | 3 | 1999 | 391 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 64 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2004 | 111 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 1998 | 3868 | 0.050 |
Why?
|
| Chromatography, Affinity | 2 | 1999 | 70 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2001 | 28 | 0.050 |
Why?
|
| Growth Cones | 1 | 2001 | 17 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 8865 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2001 | 24 | 0.050 |
Why?
|
| COS Cells | 2 | 2000 | 273 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2014 | 991 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1998 | 2696 | 0.050 |
Why?
|
| Feedback | 1 | 2002 | 162 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2001 | 55 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 177 | 0.050 |
Why?
|
| RNA, Messenger | 6 | 2009 | 2813 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2001 | 178 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2000 | 413 | 0.040 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2000 | 17 | 0.040 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2000 | 7 | 0.040 |
Why?
|
| Ouabain | 1 | 2000 | 27 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 2000 | 46 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4273 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 752 | 0.040 |
Why?
|
| Female | 6 | 2021 | 65549 | 0.040 |
Why?
|
| Longevity | 1 | 2021 | 138 | 0.040 |
Why?
|
| fas Receptor | 1 | 1999 | 41 | 0.040 |
Why?
|
| Enzymes, Immobilized | 1 | 1999 | 6 | 0.040 |
Why?
|
| Lisinopril | 1 | 1999 | 25 | 0.040 |
Why?
|
| Aged | 2 | 2015 | 19098 | 0.040 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1998 | 7 | 0.040 |
Why?
|
| Kidney Medulla | 1 | 1998 | 19 | 0.040 |
Why?
|
| Humans | 13 | 2015 | 123223 | 0.040 |
Why?
|
| Cytoprotection | 1 | 2018 | 39 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 554 | 0.040 |
Why?
|
| Immunoblotting | 1 | 1999 | 312 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 1339 | 0.040 |
Why?
|
| Caspases | 1 | 1999 | 158 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 75 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 1998 | 293 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 1584 | 0.040 |
Why?
|
| Adolescent | 1 | 2015 | 19110 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2000 | 900 | 0.040 |
Why?
|
| Adult | 2 | 2015 | 29072 | 0.040 |
Why?
|
| Stem Cells | 1 | 2002 | 700 | 0.040 |
Why?
|
| Colon | 1 | 2000 | 353 | 0.030 |
Why?
|
| Cholesterol | 1 | 2000 | 525 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 260 | 0.030 |
Why?
|
| Kinetics | 1 | 1999 | 1313 | 0.030 |
Why?
|
| Ethanol | 2 | 1994 | 162 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2006 | 113 | 0.030 |
Why?
|
| Middle Aged | 1 | 2015 | 26016 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 530 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 6221 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2006 | 766 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2002 | 2585 | 0.030 |
Why?
|
| Angiotensinogen | 1 | 1994 | 21 | 0.030 |
Why?
|
| Trypsin | 1 | 1994 | 95 | 0.030 |
Why?
|
| Renin | 1 | 1994 | 89 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1994 | 13 | 0.030 |
Why?
|
| Biliary Atresia | 1 | 1997 | 186 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1994 | 83 | 0.030 |
Why?
|
| Perilipin-2 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1993 | 174 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1695 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 1998 | 106 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2014 | 93 | 0.030 |
Why?
|
| Nephrectomy | 1 | 1994 | 172 | 0.030 |
Why?
|
| Lipoproteins, VLDL | 1 | 2013 | 58 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1998 | 773 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2013 | 59 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2014 | 256 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 184 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1994 | 1682 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 187 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 2525 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2012 | 22 | 0.030 |
Why?
|
| Retinoid X Receptors | 2 | 2002 | 33 | 0.030 |
Why?
|
| Apoptosis | 1 | 1999 | 1781 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 444 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2006 | 316 | 0.030 |
Why?
|
| Genetic Variation | 1 | 1998 | 1480 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 672 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2014 | 437 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2002 | 34 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 217 | 0.020 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2010 | 3 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 494 | 0.020 |
Why?
|
| Binding Sites | 2 | 2006 | 1291 | 0.020 |
Why?
|
| Glycogen | 1 | 2010 | 63 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3084 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2010 | 58 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2009 | 13 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2009 | 19 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 194 | 0.020 |
Why?
|
| Aging | 1 | 1996 | 1173 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 307 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 170 | 0.020 |
Why?
|
| Fatigue | 1 | 2010 | 216 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2008 | 60 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 231 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 429 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2010 | 338 | 0.020 |
Why?
|
| Lysosomes | 1 | 2009 | 232 | 0.020 |
Why?
|
| Models, Animal | 1 | 2009 | 464 | 0.020 |
Why?
|
| Biological Transport | 2 | 2000 | 347 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 424 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1682 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 675 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 98 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 667 | 0.020 |
Why?
|
| DNA | 2 | 2006 | 1592 | 0.020 |
Why?
|
| Sodium | 2 | 1998 | 291 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2006 | 91 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2009 | 496 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 661 | 0.020 |
Why?
|
| Serine | 1 | 2006 | 172 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2014 | 8108 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 389 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 2946 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 966 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 2002 | 7 | 0.010 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2002 | 28 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2002 | 61 | 0.010 |
Why?
|
| Isoxazoles | 1 | 2002 | 31 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 153 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1014 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 1441 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2002 | 269 | 0.010 |
Why?
|
| Receptor, Adenosine A3 | 1 | 2000 | 2 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1061 | 0.010 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2000 | 5 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4228 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 481 | 0.010 |
Why?
|
| Rubidium Radioisotopes | 1 | 2000 | 5 | 0.010 |
Why?
|
| Vanadates | 1 | 2000 | 12 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 179 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 87 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2000 | 27 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2002 | 230 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 2000 | 86 | 0.010 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 1999 | 6 | 0.010 |
Why?
|
| Caspase 8 | 1 | 1999 | 21 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 1999 | 29 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 33 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 64 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 473 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 2000 | 190 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 383 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 56 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 459 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 548 | 0.010 |
Why?
|
| Caspase 9 | 1 | 1999 | 75 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 279 | 0.010 |
Why?
|
| Plasmids | 1 | 2000 | 509 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1997 | 68 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1998 | 124 | 0.010 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 1997 | 22 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2000 | 226 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 54 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 348 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1997 | 382 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2000 | 254 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 85 | 0.010 |
Why?
|
| Captopril | 1 | 1996 | 28 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 258 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 892 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 623 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1265 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 2048 | 0.010 |
Why?
|
| Emphysema | 1 | 1994 | 66 | 0.010 |
Why?
|
| Swine | 1 | 1994 | 1155 | 0.010 |
Why?
|
| Neurons | 1 | 2000 | 1937 | 0.010 |
Why?
|